Physician profile
Michael B Wallace
NPI 1942299821
$24,348.52
in general payments reported to CMS, 2019-2025
8 companies · $1,312 in 2025
The $1,312 reported for 2025 was more than what a typical Gastroenterology (Internal Medicine) provider received nationally (typical 2025 total: $636).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $182 · 2020: $1,397 · 2021: $2,460 · 2022: $4,135 · 2023: $3,547 · 2024: $11K · 2025: $1,312.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $11K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $2,500 · Travel and Lodging: $1,600 · Food and Beverage: $844.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $11,230.00 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $2,500.00 |
| Travel and Lodging | $1,599.88 |
| Food and Beverage | $844.17 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $12,062.48 | 2022-2025 | Gi Genius |
| Boston Scientific Corporation | $7,120.56 | 2019-2024 | Orise |
| Olympus Corporation | $2,460.00 | 2021 | |
| Micro-Tech Endoscopy USA, INC. | $2,250.00 | 2020-2025 | |
| Steris Corporation | $194.62 | 2025 | |
| Cook Medical LLC | $125.07 | 2024 | Echotip Insight |
| Ambu INC. | $92.82 | 2024 | |
| Johnson & Johnson Health Care Systems INC. | $42.97 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Wallace listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.